Condition
Intrapartum Fetal Distress
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (2)
Trial Status
Withdrawn2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06691854Not ApplicableCompleted
Women's Perception of Respectful Maternity Care, Birth Experiences and Perception of Traumatic Birth
NCT06522854Phase 3WithdrawnPrimary
Oral Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
NCT06377098Phase 3Withdrawn
Intrapartum Sildenafil in Laboring Mothers
NCT05306756Not ApplicableTerminatedPrimary
Fetal Scalp Stimulation Versus Fetal Blood Sampling in Labour
Showing all 4 trials